Literature DB >> 18045931

Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitro.

David Warrilow1, Luke Meredith, Adam Davis, Christopher Burrell, Peng Li, David Harrich.   

Abstract

After fusion of the human immunodeficiency virus type 1 (HIV-1) envelope with the host cell membrane, the HIV-1 core enters the cell cytoplasm. Core components are then restructured to form the reverse transcription complex (RTC); the biochemical details of this process are currently unclear. To investigate early RTC formation, we characterized the endogenous reverse transcription activity of virions, which was less efficient than reverse transcription during cell infection and suggested a requirement for a cell factor. The addition of detergent to virions released reverse transcriptase and capsid, and reverse transcription products became susceptible to the action of exogenous nucleases, indicating virion disruption. Disruption was coincident with the loss of the endogenous reverse transcription activity of virions, particularly late reverse transcription products. Consistent with this observation, the use of a modified "spin thru" method, which uses brief detergent exposure, also disrupted virions. The addition of lysates made from mammalian cell lines (Jurkat, HEK293T, and NIH 3T3 cells) to virions delipidated by detergent stimulated late reverse transcription efficiency. A complex with reverse transcription activity that was slower sedimenting than virions on a velocity gradient was greatly stimulated to generate full-length reverse transcription products and was associated with only relatively small amounts of capsid. These experiments suggest that cell factors are required for efficient reverse transcription of HIV-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045931      PMCID: PMC2224456          DOI: 10.1128/JVI.01808-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.

Authors:  James A Thomas; David E Ott; Robert J Gorelick
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

2.  HIV-1 replication from after cell entry to the nuclear periphery.

Authors:  David Warrilow; David Harrich
Journal:  Curr HIV Res       Date:  2007-05       Impact factor: 1.581

Review 3.  Cyclophilin, TRIM5, and innate immunity to HIV-1.

Authors:  Elena Sokolskaja; Jeremy Luban
Journal:  Curr Opin Microbiol       Date:  2006-07-03       Impact factor: 7.934

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Deoxyribonucleic acid polymerase of Rous sarcoma virus: reaction conditions and analysis of the reaction product nucleic acids.

Authors:  D H Bishop; R Ruprecht; R W Simpson; S Spiegelman
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

6.  Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.

Authors:  H Zhang; G Dornadula; R J Pomerantz
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus.

Authors:  E Gilboa; S Goff; A Shields; F Yoshimura; S Mitra; D Baltimore
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

8.  Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. I. Kinetics of synthesis and size of minus- and plus-strand transcripts.

Authors:  L R Boone; A M Skalka
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

9.  Evidence against a direct antiviral activity of the proteasome during the early steps of HIV-1 replication.

Authors:  Megan Dueck; John Guatelli
Journal:  Virology       Date:  2007-02-21       Impact factor: 3.616

10.  The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.

Authors:  Yasuo Ariumi; Fatima Serhan; Priscilla Turelli; Amalio Telenti; Didier Trono
Journal:  Retrovirology       Date:  2006-08-05       Impact factor: 4.602

View more
  29 in total

Review 1.  The unexpected roles of eukaryotic translation elongation factors in RNA virus replication and pathogenesis.

Authors:  Dongsheng Li; Ting Wei; Catherine M Abbott; David Harrich
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

2.  A post-entry role for CD63 in early HIV-1 replication.

Authors:  Guangyu Li; Natallia Dziuba; Brian Friedrich; James L Murray; Monique R Ferguson
Journal:  Virology       Date:  2011-02-26       Impact factor: 3.616

Review 3.  Early events of HIV-1 infection: can signaling be the next therapeutic target?

Authors:  Kate L Jones; Redmond P Smyth; Cândida F Pereira; Paul U Cameron; Sharon R Lewin; Anthony Jaworowski; Johnson Mak
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-05       Impact factor: 4.147

4.  Tetraspanin CD63 is a regulator of HIV-1 replication.

Authors:  Enqing Fu; Lei Pan; Yonghong Xie; Deguang Mu; Wei Liu; Faguang Jin; Xuefan Bai
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Inhibition of reverse transcriptase activity increases stability of the HIV-1 core.

Authors:  Yang Yang; Thomas Fricke; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 6.  HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.

Authors:  Zandrea Ambrose; Christopher Aiken
Journal:  Virology       Date:  2014-02-20       Impact factor: 3.616

7.  A lectin isolated from bananas is a potent inhibitor of HIV replication.

Authors:  Michael D Swanson; Harry C Winter; Irwin J Goldstein; David M Markovitz
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

8.  The RNA binding protein HuR does not interact directly with HIV-1 reverse transcriptase and does not affect reverse transcription in vitro.

Authors:  Jinwoo Ahn; In-Ja L Byeon; Sanjeewa Dharmasena; Kelly Huber; Jason Concel; Angela M Gronenborn; Nicolas Sluis-Cremer
Journal:  Retrovirology       Date:  2010-05-07       Impact factor: 4.602

9.  Strand transfer and elongation of HIV-1 reverse transcription is facilitated by cell factors in vitro.

Authors:  David Warrilow; Kylie Warren; David Harrich
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

10.  Potent inhibition of HIV-1 replication by a Tat mutant.

Authors:  Luke W Meredith; Haran Sivakumaran; Lee Major; Andreas Suhrbier; David Harrich
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.